ANL 33.20 Decreased By ▼ -0.60 (-1.78%)
ASC 14.69 Decreased By ▼ -0.44 (-2.91%)
ASL 24.42 Decreased By ▼ -1.08 (-4.24%)
AVN 91.85 Decreased By ▼ -3.65 (-3.82%)
BOP 9.03 Decreased By ▼ -0.14 (-1.53%)
BYCO 9.75 Decreased By ▼ -0.48 (-4.69%)
DGKC 131.75 Decreased By ▼ -5.75 (-4.18%)
EPCL 50.00 Decreased By ▼ -1.62 (-3.14%)
FCCL 24.41 Decreased By ▼ -0.59 (-2.36%)
FFBL 24.40 Decreased By ▼ -1.05 (-4.13%)
FFL 15.10 Decreased By ▼ -0.60 (-3.82%)
HASCOL 10.53 Decreased By ▼ -0.37 (-3.39%)
HUBC 84.90 Decreased By ▼ -1.85 (-2.13%)
HUMNL 6.70 Decreased By ▼ -0.40 (-5.63%)
JSCL 25.65 Decreased By ▼ -1.39 (-5.14%)
KAPCO 38.65 Decreased By ▼ -1.35 (-3.38%)
KEL 3.99 Decreased By ▼ -0.16 (-3.86%)
LOTCHEM 14.37 Decreased By ▼ -0.43 (-2.91%)
MLCF 45.91 Decreased By ▼ -1.68 (-3.53%)
PAEL 36.84 Decreased By ▼ -1.46 (-3.81%)
PIBTL 11.54 Decreased By ▼ -0.37 (-3.11%)
POWER 10.20 Decreased By ▼ -0.50 (-4.67%)
PPL 90.00 Decreased By ▼ -0.97 (-1.07%)
PRL 26.52 Decreased By ▼ -0.93 (-3.39%)
PTC 8.64 Decreased By ▼ -0.17 (-1.93%)
SILK 1.35 Decreased By ▼ -0.05 (-3.57%)
SNGP 41.50 Decreased By ▼ -2.25 (-5.14%)
TRG 144.02 Decreased By ▼ -3.68 (-2.49%)
UNITY 30.00 Decreased By ▼ -1.20 (-3.85%)
WTL 1.43 Decreased By ▼ -0.09 (-5.92%)
BR100 4,895 Decreased By ▼ -120.5 (-2.4%)
BR30 25,312 Decreased By ▼ -818.47 (-3.13%)
KSE100 45,398 Decreased By ▼ -759.72 (-1.65%)
KSE30 18,935 Decreased By ▼ -372.15 (-1.93%)
World

Brazilian clinics to buy India's COVAXIN vaccine pending approval

  • Private sector talks to acquire Bharat's COVAXIN vaccine would not interfere with the Brazilian government's efforts to acquire vaccines for the public sector.
  • Bharat Biotech said on Tuesday that it had signed an agreement with a Brazil-based pharmaceutical seller, Precisa Medicamentos, to supply the vaccine even though it has yet to be approved.
13 Jan 2021

SAO PAULO: Brazil's private sector vaccine clinics will be able to give customers a COVID-19 shot developed by India's Bharat Biotech once Brazil's federal health regulator has approved the drug, the head of the Brazilian Association of Vaccine Clinics (ABCVAC) said on Wednesday.

Speaking after a trip to visit Bharat Biotech executives in India, ABCVAC President Geraldo Barbosa said that private sector talks to acquire Bharat's COVAXIN vaccine would not interfere with the Brazilian government's efforts to acquire vaccines for the public sector.

Barbosa said that private clinics would only be able to buy the vaccine once health regulator Anvisa has signed off on the drug. He did not say whether a deal with Bharat had been signed, nor did he provide specific numbers on the size of any order.

Brazil's President Jair Bolsonaro is under mounting pressure because of the slow pace of the country's vaccine rollout. Inoculations have yet to begin in Latin America's largest country and Anvisa has yet to approve any vaccine for use.

Bharat Biotech said on Tuesday that it had signed an agreement with a Brazil-based pharmaceutical seller, Precisa Medicamentos, to supply the vaccine even though it has yet to be approved.